Wei W B, Yang J Y
Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing 100730, China.
Zhonghua Yan Ke Za Zhi. 2023 Mar 11;59(3):165-168. doi: 10.3760/cma.j.cn112142-20221228-00661.
Diabetic retinopathy (DR) is one of the severe complications of diabetes, and also the most common reason of vision loss in Chinese adults over 30 years old. Regular fundus examination and continuous glucose monitoring can prevent 98% of blindness caused by DR. However, due to the irrational allocation of medical resources and the weak awareness of DR patients, only about 50% to 60% of diabetes patients have an annual DR screening. Therefore, it is necessary to build a follow-up system for early screening, prevention, treatment and lifelong monitoring of DR patients. In this review, we discuss the importance of lifelong monitoring, the hierarchical medical system and the follow-up of pediatric DR patients. Novel and multi-level screening methods are cost-saving to patients and cost-effective to healthcare systems, and also can help improve the detection and early treatment of DR.
糖尿病视网膜病变(DR)是糖尿病的严重并发症之一,也是中国30岁以上成年人视力丧失的最常见原因。定期眼底检查和持续血糖监测可预防98%由DR导致的失明。然而,由于医疗资源分配不合理以及DR患者意识淡薄,只有约50%至60%的糖尿病患者每年进行DR筛查。因此,有必要建立一个针对DR患者的早期筛查、预防、治疗和终身监测的随访系统。在本综述中,我们讨论了终身监测、分级医疗系统以及儿童DR患者随访的重要性。新颖的多级筛查方法对患者而言节省费用,对医疗系统而言具有成本效益,还能有助于提高DR的检测和早期治疗。